Method Profile
Add external ventilation to a linked drug-exposure, receptor-binding and cardiopulmonary model, then compare arrest and breathing-recovery outcomes under defined intervention assumptions.
Investigate interaction between pharmacological reversal and respiratory support in modeled overdose scenarios.
2,000 virtual chronic opioid users; intravenous, transmucosal and oral fentanyl scenarios calibrated to approximately 50% cardiac arrest without intervention.
Model-imposed naloxone comparators: 2 mg intramuscular, 4 mg intranasal and 8 mg intranasal, each with or without externally imposed ventilation. Main timing is one minute after respiratory depression for naloxone and immediate model-apnea onset for rescue breathing; ten-minute artificial ventilation limit with duration sensitivity analysis. These are simulation inputs.
Mechanistic components
Previously developed pharmacokinetic, receptor-binding, pharmacodynamic and cardiopulmonary physiology submodels; new external-ventilation input.
Scenario assumptions
Main population mixture: 320 subjects at 80% baseline ventilation and 1,680 at 40%; separate uniformly higher-quality scenario. Cardiac arrest below 5% defines simulated success.
Keep formulation/absorption-route effects, intervention timing, ventilation quality and spontaneous recovery distinct. Report virtual-population denominators and the origin of inherited component validation.
Extend an earlier component-validated model and compare single/combined intervention scenarios; vary delay, quality and duration.
2,000 virtual subjects. Population uncertainty bars use repeated samples of 200 subjects drawn 2,500 times; this is resampling of a simulated population.
No intervention, naloxone alone, external ventilation alone and combined intervention; community-quality mixture versus uniformly higher-quality input.
Combined interventions reduced modeled arrest rates across tested routes. In the severe quality comparison, higher-quality ventilation produced less than 5% arrest; adding modeled 4 mg intranasal naloxone shortened median spontaneous-breathing recovery from 411 to 178 seconds.
FDA researchers added an external-ventilation component to a mechanistic opioid-overdose model. Across simulated fentanyl exposures, combined interventions reduced cardiac-arrest estimates, while ventilation quality and absorption route changed the result and naloxone accelerated recovery of spontaneous breathing.
